{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T08:26:08Z","timestamp":1782289568712,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Technology Innovation Project funded by Science and Technology Bureau of Shapingba District, Chongqing","award":["2024146"],"award-info":[{"award-number":["2024146"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-03958-0","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T14:31:29Z","timestamp":1753367489000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Optimizing intraoperative radiotherapy as a tumor bed boost with whole-breast irradiation in breast cancer"],"prefix":"10.1186","volume":"23","author":[{"given":"Jing","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Gui","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-Qian","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Zhong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hua","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Yan","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"key":"3958_CR1","doi-asserted-by":"publisher","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024 May-Jun;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","DOI":"10.3322\/caac.21834"},{"issue":"1","key":"3958_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","volume":"4","author":"B Han","year":"2024","unstructured":"Han B, Zheng R, Zeng H, Wang S, Sun K, Chen R, Li L, Wei W, He J. Cancer incidence and mortality in china, 2022. J Natl Cancer Cent. 2024;4(1):47\u201353. https:\/\/doi.org\/10.1016\/j.jncc.2024.01.006.","journal-title":"J Natl Cancer Cent"},{"issue":"9503","key":"3958_CR3","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","volume":"366","author":"M Clarke","year":"2005","unstructured":"Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V, Godwin J, Gray R, Hicks C, James S, MacKinnon E, McGale P, McHugh T, Peto R, Taylor C, Wang Y, Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366(9503):2087\u2013106. https:\/\/doi.org\/10.1016\/S0140-6736(05)67887-7.","journal-title":"Lancet"},{"issue":"9804","key":"3958_CR4","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","volume":"378","author":"S Darby","year":"2011","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG), Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, Cutter D, Davies C, Ewertz M, Godwin J, Gray R, Pierce L, Whelan T, Wang Y, Peto R. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378(9804):1707\u201316. https:\/\/doi.org\/10.1016\/S0140-6736(11)61629-2.","journal-title":"Lancet"},{"issue":"16","key":"3958_CR5","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1056\/NEJMoa022152","volume":"347","author":"B Fisher","year":"2002","unstructured":"Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233\u201341. https:\/\/doi.org\/10.1056\/NEJMoa022152.","journal-title":"N Engl J Med"},{"issue":"5","key":"3958_CR6","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/0360-3016(95)02176-0","volume":"34","author":"F Sedlmayer","year":"1996","unstructured":"Sedlmayer F, Rahim HB, Kogelnik HD, Menzel C, Merz F, Deutschmann H, Kranzinger M. Quality assurance in breast cancer brachytherapy: geographic miss in the interstitial boost treatment of the tumor bed. Int J Radiat Oncol Biol Phys. 1996;34(5):1133\u20139. https:\/\/doi.org\/10.1016\/0360-3016(95)02176-0.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"22","key":"3958_CR7","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1200\/JCO.2007.11.4991","volume":"25","author":"H Bartelink","year":"2007","unstructured":"Bartelink H, Horiot JC, Poortmans PM, Struikmans H, Van den Bogaert W, Fourquet A, Jager JJ, Hoogenraad WJ, Oei SB, W\u00e1rl\u00e1m-Rodenhuis CC, Pierart M, Collette L. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881\u2013\u200910882 trial. J Clin Oncol. 2007;25(22):3259\u201365. https:\/\/doi.org\/10.1200\/JCO.2007.11.4991.","journal-title":"J Clin Oncol"},{"issue":"16","key":"3958_CR8","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1056\/NEJMoa020989","volume":"347","author":"U Veronesi","year":"2002","unstructured":"Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, Aguilar M, Marubini E. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347(16):1227\u201332. https:\/\/doi.org\/10.1056\/NEJMoa020989.","journal-title":"N Engl J Med"},{"issue":"4","key":"3958_CR9","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/1097-0142(20010215)91:4<647::aid-cncr1053>3.0.co;2-z","volume":"91","author":"DR Faverly","year":"2001","unstructured":"Faverly DR, Hendriks JH, Holland R. Breast carcinomas of limited extent: frequency, radiologic-pathologic characteristics, and surgical margin requirements. Cancer. 2001;91(4):647\u201359. https:\/\/doi.org\/10.1002\/1097-0142(20010215)91:4<647::aid-cncr1053>3.0.co;2-z.","journal-title":"Cancer"},{"issue":"5","key":"3958_CR10","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1002\/1097-0142(19850901)56:5<979::aid-cncr2820560502>3.0.co;2-n","volume":"56","author":"R Holland","year":"1985","unstructured":"Holland R, Veling SH, Mravunac M, Hendriks JH. Histologic multifocality of tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer. 1985;56(5):979\u201390. https:\/\/doi.org\/10.1002\/1097-0142(19850901)56:5<979::aid-cncr2820560502>3.0.co;2-n.","journal-title":"Cancer"},{"key":"3958_CR11","unstructured":"Fisher ER, Anderson S, Redmond C, Fisher B. Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: pathological findings from NSABP protocol B-06. Semin Surg oncol. 1992 May-Jun;8(3):161\u20136."},{"issue":"13","key":"3958_CR12","doi-asserted-by":"publisher","first-page":"8436","DOI":"10.1245\/s10434-023-13955-w","volume":"30","author":"J He","year":"2023","unstructured":"He J, Chen S, Ye L, Sun Y, Dai Y, Song X, Lin X, Xu R. Intraoperative radiotherapy as a Tumour-Bed boost combined with whole breast irradiation versus conventional radiotherapy in patients with Early-Stage breast cancer: A systematic review and Meta-analysis. Ann Surg Oncol. 2023;30(13):8436\u201352. https:\/\/doi.org\/10.1245\/s10434-023-13955-w.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"3958_CR13","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228\u201347. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026.","journal-title":"Eur J Cancer"},{"issue":"5","key":"3958_CR14","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","volume":"31","author":"JD Cox","year":"1995","unstructured":"Cox JD, Stetz J, Pajak TF. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31(5):1341\u20136. https:\/\/doi.org\/10.1016\/0360-3016(95)00060-C.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"13","key":"3958_CR15","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S1470-2045(13)70497-2","volume":"14","author":"U Veronesi","year":"2013","unstructured":"Veronesi U, Orecchia R, Maisonneuve P, Viale G, Rotmensz N, Sangalli C, Luini A, Veronesi P, Galimberti V, Zurrida S, Leonardi MC, Lazzari R, Cattani F, Gentilini O, Intra M, Caldarella P, Ballardini B. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol. 2013;14(13):1269\u201377. https:\/\/doi.org\/10.1016\/S1470-2045(13)70497-2.","journal-title":"Lancet Oncol"},{"issue":"5","key":"3958_CR16","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1470-2045(21)00080-2","volume":"22","author":"R Orecchia","year":"2021","unstructured":"Orecchia R, Veronesi U, Maisonneuve P, Galimberti VE, Lazzari R, Veronesi P, Jereczek-Fossa BA, Cattani F, Sangalli C, Luini A, Caldarella P, Venturino M, Sances D, Zurrida S, Viale G, Leonardi MC, Intra M. Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial. Lancet Oncol. 2021;22(5):597\u2013608. https:\/\/doi.org\/10.1016\/S1470-2045(21)00080-2.","journal-title":"Lancet Oncol"},{"issue":"9735","key":"3958_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0140-6736(10)60837-9","volume":"376","author":"JS Vaidya","year":"2010","unstructured":"Vaidya JS, Joseph DJ, Tobias JS, Bulsara M, Wenz F, Saunders C, Alvarado M, Flyger HL, Massarut S, Eiermann W, Keshtgar M, Dewar J, Kraus-Tiefenbacher U, S\u00fctterlin M, Esserman L, Holtveg HM, Roncadin M, Pigorsch S, Metaxas M, Falzon M, Matthews A, Corica T, Williams NR, Baum M. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet. 2010;376(9735):91\u2013102. https:\/\/doi.org\/10.1016\/S0140-6736(10)60837-9.","journal-title":"Lancet"},{"key":"3958_CR18","doi-asserted-by":"publisher","first-page":"m2836","DOI":"10.1136\/bmj.m2836","volume":"370","author":"JS Vaidya","year":"2020","unstructured":"Vaidya JS, Bulsara M, Baum M, Wenz F, Massarut S, Pigorsch S, Alvarado M, Douek M, Saunders C, Flyger HL, Eiermann W, Brew-Graves C, Williams NR, Potyka I, Roberts N, Bernstein M, Brown D, Sperk E, Laws S, S\u00fctterlin M, Corica T, Lundgren S, Holmes D, Vinante L, Bozza F, Pazos M, Le Blanc-Onfroy M, Gruber G, Polkowski W, Dedes KJ, Niewald M, Blohmer J, McCready D, Hoefer R, Kelemen P, Petralia G, Falzon M, Joseph DJ, Tobias JS. Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial. BMJ. 2020;370:m2836. https:\/\/doi.org\/10.1136\/bmj.m2836.","journal-title":"BMJ"},{"issue":"1","key":"3958_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13058-021-01424-9","volume":"23","author":"A Ciabattoni","year":"2021","unstructured":"Ciabattoni A, Gregucci F, Fastner G, Cavuto S, Spera A, Drago S, Ziegler I, Mirri MA, Consorti R, Sedlmayer F. IOERT versus external beam electrons for boost radiotherapy in stage I\/II breast cancer: 10-year results of a phase III randomized study. Breast Cancer Res. 2021;23(1):46. https:\/\/doi.org\/10.1186\/s13058-021-01424-9.","journal-title":"Breast Cancer Res"},{"issue":"Suppl 3","key":"3958_CR20","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1245\/s10434-010-1257-z","volume":"17","author":"G Welzel","year":"2010","unstructured":"Welzel G, Hofmann F, Blank E, Kraus-Tiefenbacher U, Hermann B, S\u00fctterlin M, Wenz F. Health-related quality of life after breast-conserving surgery and intraoperative radiotherapy for breast cancer using low-kilovoltage X-rays. Ann Surg Oncol. 2010;17(Suppl 3):359\u201367. https:\/\/doi.org\/10.1245\/s10434-010-1257-z.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"3958_CR21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1159\/000091160","volume":"29","author":"U Kraus-Tiefenbacher","year":"2006","unstructured":"Kraus-Tiefenbacher U, Bauer L, Kehrer T, Hermann B, Melchert F, Wenz F. Intraoperative radiotherapy (IORT) as a boost in patients with early-stage breast cancer -- acute toxicity. Onkologie. 2006;29(3):77\u201382. https:\/\/doi.org\/10.1159\/000091160.","journal-title":"Onkologie"},{"key":"3958_CR22","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.breast.2018.04.004","volume":"39","author":"L Sorrentino","year":"2018","unstructured":"Sorrentino L, Fissi S, Meaglia I, Bossi D, Caserini O, Mazzucchelli S, Truffi M, Albasini S, Tabarelli P, Liotta M, Ivaldi GB, Corsi F. One-step intraoperative radiotherapy optimizes Conservative treatment of breast cancer with advantages in quality of life and work resumption. Breast. 2018;39:123\u201330. https:\/\/doi.org\/10.1016\/j.breast.2018.04.004.","journal-title":"Breast"},{"issue":"5","key":"3958_CR23","doi-asserted-by":"publisher","first-page":"e1376","DOI":"10.1002\/cnr2.1376","volume":"4","author":"P Fadavi","year":"2021","unstructured":"Fadavi P, Nafissi N, Mahdavi SR, Jafarnejadi B, Javadinia SA. Outcome of hypofractionated breast irradiation and intraoperative electron boost in early breast cancer: A randomized non-inferiority clinical trial. Cancer Rep (Hoboken). 2021;4(5):e1376. https:\/\/doi.org\/10.1002\/cnr2.1376.","journal-title":"Cancer Rep (Hoboken)"},{"issue":"3","key":"3958_CR24","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.radonc.2018.06.020","volume":"128","author":"PJAM Brouwers","year":"2018","unstructured":"Brouwers PJAM, van Werkhoven E, Bartelink H, Fourquet A, Lemanski C, van Loon J, Maduro JH, Russell NS, Scheijmans LJEE, Schinagl DAX, Westenberg AH, Poortmans P, Boersma LJ. Young boost trial research group. Predictors for poor cosmetic outcome in patients with early stage breast cancer treated with breast conserving therapy: results of the young boost trial. Radiother Oncol. 2018;128(3):434\u201341. https:\/\/doi.org\/10.1016\/j.radonc.2018.06.020.","journal-title":"Radiother Oncol"},{"issue":"6","key":"3958_CR25","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.breast.2008.05.009","volume":"17","author":"F Wenz","year":"2008","unstructured":"Wenz F, Welzel G, Keller A, Blank E, Vorodi F, Herskind C, Tom\u00e9 O, S\u00fctterlin M, Kraus -T, iefenbacher U. Early initiation of external beam radiotherapy (EBRT) May increase the risk of long-term toxicity in patients undergoing intraoperative radiotherapy (IORT) as a boost for breast cancer. Breast. 2008;17(6):617\u201322. https:\/\/doi.org\/10.1016\/j.breast.2008.05.009.","journal-title":"Breast"},{"issue":"740","key":"3958_CR26","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1259\/0007-1285-62-740-679","volume":"62","author":"JF Fowler","year":"1989","unstructured":"Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 1989;62(740):679\u201394. https:\/\/doi.org\/10.1259\/0007-1285-62-740-679.","journal-title":"Br J Radiol"},{"issue":"9618","key":"3958_CR27","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/S0140-6736(08)60348-7","volume":"371","author":"SM Bentzen","year":"2008","unstructured":"START Trialists\u2019 Group, Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bentzen SM, Bliss JM, Brown J, Dewar JA, Dobbs HJ, Haviland JS, Hoskin PJ, Hopwood P, Lawton PA, Magee BJ, Mills J, Morgan DA, Owen JR, Simmons S, Sumo G, Sydenham MA, Venables K, Yarnold JR. The UK standardisation of breast radiotherapy (START) trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet. 2008;371(9618):1098\u2013107. https:\/\/doi.org\/10.1016\/S0140-6736(08)60348-7.","journal-title":"Lancet"},{"issue":"4","key":"3958_CR28","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.semradonc.2008.04.008","volume":"18","author":"TJ Whelan","year":"2008","unstructured":"Whelan TJ, Kim DH, Sussman J. Clinical experience using hypofractionated radiation schedules in breast cancer. Semin Radiat Oncol. 2008;18(4):257\u201364. https:\/\/doi.org\/10.1016\/j.semradonc.2008.04.008.","journal-title":"Semin Radiat Oncol"},{"issue":"17","key":"3958_CR29","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1016\/s0959-8049(01)00284-2","volume":"37","author":"H Bartelink","year":"2001","unstructured":"Bartelink H. Commentary on the paper A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. A critical review of an innovative approach. Eur J Cancer. 2001;37(17):2143\u20136. https:\/\/doi.org\/10.1016\/s0959-8049(01)00284-2.","journal-title":"Eur J Cancer"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03958-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-03958-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03958-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T14:31:30Z","timestamp":1753367490000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-03958-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3958"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-03958-0","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,24]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted with approval from the Ethics Committee of Chongqing University Cancer Hospital (Approval Number: CZLS2024189-B). This study was conducted in accordance with the declaration of Helsinki. Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"298"}}